Thromboangiitis Obliterans
📧 Sign up to get email alerts when something new happens for Thromboangiitis Obliterans.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-15Clinical Trial Update: A First in Human Single Ascending Dose (SAD) Study of ATI-1013 in Healthy Smokers [Phase 1]
First-in-human Phase 1 single ascending dose study of ATI-1013 in healthy smokers, investigating treatment for Thromboangiitis Obliterans (B…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
A follow-up gene therapy trial for critical limb ischemia is currently enrolling by invitation, sponsored by Beijing Northland Biotech Co., …
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Evaluation of Botulinum TOXin Type a in the Treatment of Buerger's Disease [Phase 3]
Phase 3 clinical trial evaluating botulinum toxin type A for Thromboangiitis Obliterans (Buerger's disease) and Raynaud phenomenon; the stud…
-
CLINICAL_TRIALS research · 2016-04-19Clinical Trial Update: Purified CD34+ Cells Versus Peripheral Blood Mononuclear Cells in Treatment of Critical Limb Ischemia [NA]
A clinical trial compares purified CD34+ cell therapy to peripheral blood mononuclear cells for treating critical limb ischemia, sponsored b…